Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Maga

Showing results (111-120 of 214) with videos related to

Pageof 22
Sort By:
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Identification and Biological Characterization of the Pyrazolo[3,4-<i>d</i>]pyrimidine Derivative SI388 Active as Src InhibitorClaudia Contadini, Claudia Cirotti, Anna Carbone, et al.
European Journal of Medicinal Chemistry|July 31, 2016
Novel pyrazolo[3,4-d]pyrimidines as dual Src-Abl inhibitors active against mutant form of Abl and the leukemia K-562 cell lineSamir M El-Moghazy, Riham F George, Essam Eldin A Osman, et al.
Biochemistry|April 29, 2010
DNA polymerases beta and lambda bypass thymine glycol in gapped DNA structuresEkaterina A Belousova, Giovanni Maga, Yang Fan, et al.
Angewandte Chemie (International Ed. in English)|February 3, 2007
Discovery of non-nucleoside inhibitors of HIV-1 reverse transcriptase competing with the nucleotide substrateGiovanni Maga, Marco Radi, Samantha Zanoli, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2012
Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitorsMarco Radi, Federico Falchi, Anna Garbelli, et al.
Journal of Medicinal Chemistry|March 29, 2011
Diarylpyrimidine-dihydrobenzyloxopyrimidine hybrids: new, wide-spectrum anti-HIV-1 agents active at (sub)-nanomolar levelDante Rotili, Domenico Tarantino, Marino Artico, et al.
European Journal of Medicinal Chemistry|January 12, 2017
Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against GlioblastomaFrancesca Musumeci, Anna Lucia Fallacara, Chiara Brullo, et al.
Frontiers in Plant Science|December 31, 2020
Plant Molecular Farming as a Strategy Against COVID-19 - The Italian PerspectiveChiara Lico, Luca Santi, Selene Baschieri, et al.
Molecular and Cellular Biology|April 16, 2005
The human stress-activated protein kin17 belongs to the multiprotein DNA replication complex and associates in vivo with mammalian replication originsLaurent Miccoli, Isabelle Frouin, Olivia Novac, et al.
Bioorganic & Medicinal Chemistry|February 25, 2005
5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO familyAntonello Mai, Marino Artico, Rino Ragno, et al.
Pageof 22

Showing results (111-120 of 214) with videos related to

Sort By:
Pageof 22
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Identification and Biological Characterization of the Pyrazolo[3,4-<i>d</i>]pyrimidine Derivative SI388 Active as Src InhibitorClaudia Contadini, Claudia Cirotti, Anna Carbone, et al.
European Journal of Medicinal Chemistry|July 31, 2016
Novel pyrazolo[3,4-d]pyrimidines as dual Src-Abl inhibitors active against mutant form of Abl and the leukemia K-562 cell lineSamir M El-Moghazy, Riham F George, Essam Eldin A Osman, et al.
Biochemistry|April 29, 2010
DNA polymerases beta and lambda bypass thymine glycol in gapped DNA structuresEkaterina A Belousova, Giovanni Maga, Yang Fan, et al.
Angewandte Chemie (International Ed. in English)|February 3, 2007
Discovery of non-nucleoside inhibitors of HIV-1 reverse transcriptase competing with the nucleotide substrateGiovanni Maga, Marco Radi, Samantha Zanoli, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2012
Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitorsMarco Radi, Federico Falchi, Anna Garbelli, et al.
Journal of Medicinal Chemistry|March 29, 2011
Diarylpyrimidine-dihydrobenzyloxopyrimidine hybrids: new, wide-spectrum anti-HIV-1 agents active at (sub)-nanomolar levelDante Rotili, Domenico Tarantino, Marino Artico, et al.
European Journal of Medicinal Chemistry|January 12, 2017
Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against GlioblastomaFrancesca Musumeci, Anna Lucia Fallacara, Chiara Brullo, et al.
Frontiers in Plant Science|December 31, 2020
Plant Molecular Farming as a Strategy Against COVID-19 - The Italian PerspectiveChiara Lico, Luca Santi, Selene Baschieri, et al.
Molecular and Cellular Biology|April 16, 2005
The human stress-activated protein kin17 belongs to the multiprotein DNA replication complex and associates in vivo with mammalian replication originsLaurent Miccoli, Isabelle Frouin, Olivia Novac, et al.
Bioorganic & Medicinal Chemistry|February 25, 2005
5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO familyAntonello Mai, Marino Artico, Rino Ragno, et al.
Pageof 22